Clinical case – Immune Check Point Inhibitor in the perioperative setting for MIBC
2020-12-10
Dr. Benjamin Pradere (FR) and his colleagues discuss outcomes of using an Immune Check Point Inhibitor in the Perioperative Setting for muscle-invasive bladder cancer (MIBC).
